Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guanbin Zhang has a total of 143 co-authors. Here are the top co-authors by number of shared publications:

  • Dong Wang

    School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China

    5 shared publications
  • Huili Wang

    Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China

    3 shared publications
  • Kequan Lin

    Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China

    3 shared publications
  • Wei Shao

    Iomics Biosciences Inc., Beijing, China

    3 shared publications
  • Xiankuo Yu

    School of Basic Medical Sciences, State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    3 shared publications
  • Xiaoying Lin

    Research and Development Department, Fujian CapitalBio Medical Laboratory, Fuzhou, China

    3 shared publications

Latest Publications

  • Open Access

    Digital Behavioral Risk Stratification Tool Integrated With HIV Online Self-Testing for HIV Positivity Among Men Who Have Sex With Men: Retrospective Observational Study

    by Wencheng Liu, Yan Jiang, Guanbin Zhang, Yi Lv

    Background: Due to concerns about privacy breaches and the fear of social stigma, some individuals engaging in high-risk behaviors—particularly men who have sex with men (MSM)—may avoid in-person HIV testing services and instead choose to purchase HIV self-test kits online. Unlike traditional e-commerce platforms that provide self-test kits directly without conducting risk assessments, the “Easy Test Know” platform integrates a structured behavioral risk assessment prior to purchasing an HIV self-test kit, allowing users to be categorized into different HIV risk groups. Objective: This study aimed to evaluate the performance of a digital HIV behavioral risk stratification tool integrated with online self-testing among MSM and to determine whether incorporating multidimensional behavioral indicators—particularly the high-risk venue diversity score—could improve the prediction of HIV positivity compared with the platform’s existing rule-based risk-scoring algorithm. Methods: This retrospective observational study used data from the “Easy Test Know” platform between November 2023 and February 2025. The analysis included 9961 MSM classified as medium or high risk who had a usable HIV test result. The continuous platform score and the deployed categorical output were evaluated, and enhanced and fully adjusted Firth logistic regression models were compared using areas under the receiver operating characteristic curves (AUCs) with stratified bootstrap 95% CIs, DeLong tests, calibration measures, and bootstrap optimism correction based on 1000 successful model refits. Results: Among 9961 participants, 9044 (90.8%) were classified as high risk, and 58 (0.58%) had an observed HIV-positive result. Positivity was 0.6% (n=54) in the high-risk group and 0.4% (4/914) in the medium-risk group, but the difference was not statistically significant ( P =.70). The deployed categorical output had an AUC of 0.512 (95% CI 0.477‐0.539), with 93.1% (54/58) sensitivity and 9.2% (913/9903) specificity, whereas the continuous platform score had an AUC of 0.646 (95% CI 0.567‐0.725). Each 1-category increase in high-risk venue diversity was associated with higher odds of observed HIV positivity (odds ratio 2.04, 95% CI 1.53‐2.74; P for trend <.001). The enhanced and fully adjusted models had apparent AUCs of 0.728 (95% CI 0.656‐0.801) and 0.752 (95% CI 0.686‐0.817) and optimism-corrected AUCs of 0.688 and 0.713, respectively. Their optimism-corrected calibration slopes were 0.940 and 0.936. Conclusions: Compared with the platform’s original rule-based scoring system, the data-driven behavioral models incorporating high-risk venue diversity showed improved predictive performance, although bootstrap optimism correction yielded more conservative estimates. These findings support further development and independent validation of data-driven approaches to optimize digital HIV risk assessment tools.

  • Open Access

    Enhancing Early HIV Detection Among Men Who Have Sex with Men: A Real-World Evaluation of a Digital Behavioral Risk Stratification Tool Integrated with Online Self-Testing (Preprint)

    by Wencheng Liu, Yan Jiang, Guanbin Zhang, Yi Lv

    BACKGROUND Due to concerns about privacy breaches and fear of social stigma, some individuals engaging in high-risk behaviors—particularly men who have sex with men (MSM)—may avoid in-person HIV testing services and instead choose to purchase HIV self-test kits online for self-testing. Unlike traditional e-commerce platforms that directly provide self-test kits without conducting risk assessments, the “Easy Test Know” platform integrates a structured behavioral risk assessment prior to HIVST kit purchase, allowing users to be categorized into different HIV risk groups. OBJECTIVE This study aimed to evaluate the performance of a digital HIV behavioral risk stratification tool integrated with online self-testing among MSM, and to determine whether incorporating multi-dimensional behavioral indicators—particularly high-risk venue diversity score—could improve the prediction of HIV positivity compared with the platform’s existing rule-based risk scoring algorithm. METHODS This retrospective observational study utilized data from the “Easy Test Know” platform between November 2023 and February 2025. The study included MSM classified as medium or high risk by the platform algorithm. Firth logistic regression models were developed to predict HIV positivity using behavioral variables, including high-risk venue diversity score. Model performance was evaluated using area under the receiver operating characteristic curve (AUC) and calibration analyses. RESULTS A total of 9,961 participants were included, of whom 90.8% were classified as high risk by the platform. The overall HIV positivity rate was 0.59%, with a higher rate in the high-risk group. The platform’s baseline risk score demonstrated moderate discriminatory power for predicting HIV positivity (AUC = 0.646). High-risk venue diversity score showed a dose–response association with HIV positivity. The data-driven model incorporating the platform’s existing variables together with the newly derived high-risk venue diversity score improved discrimination compared with the rule-based platform algorithm (ΔAUC = +0.082). The fully adjusted model achieved the highest predictive performance (AUC = 0.752). CONCLUSIONS Digital behavioral risk stratification demonstrated moderate ability to differentiate HIV risk among MSM using online HIV self-testing services. Compared with the platform’s original rule-based scoring system, data-driven behavioral models incorporating high-risk venue diversity score showed improved predictive performance. These findings support the potential value of data-driven approaches for optimizing digital HIV risk assessment tools.

  • Open Access

    Cross-sectional study of respiratory virus infections in upper respiratory tract infection patients: post-COVID-19 pandemic trends in Sichuan, China

    by Ying Li, Wei Yin, Li Zhang, Ming Sun, Qun Yang, Sheng Ren, Xiaoying Lin, Jinsong Liu, Jiawen Yang, Shuyao Zhu, et al.

    Objectives Post-COVID-19 respiratory infection patterns require updated epidemiological data. To investigate the prevalence and infection patterns of upper respiratory tract infections (URTIs), a survey was conducted to assess the presence of influenza A (IFV A), influenza B (IFV B), respiratory syncytial virus (RSV), human rhinovirus (HRV), adenovirus (Adv), and SARS-CoV-2 among outpatients diagnosed with URTIs. Design A community-based cross-sectional study. Setting Three cities in Sichuan, China. Participants 1174 outpatients diagnosed with URTIs from December 2023 to February 2024. Methods Oropharyngeal swabs were collected using sterile flocked swabs, preserved at 4°C and analysed within 24 hours. Viral nucleic acid was extracted automatically and detected via multiplex PCR-melting curve analysis. Results Results showed in positive detection rates varied significantly by age (pConclusions This study reveals persistent influenza dominance and age-stratified co-infection risks and provides critical baseline data for optimising respiratory infectious disease control in the post-pandemic era.


  • Open Access

    Spatiotemporal heterogeneity of online HIV self-testing sales and its potential driving factors in China, 2015–2020: a retrospective nationwide study

    by Yi Lv, Qiyu Zhu, Chengdong Xu, Yan Jiang, Yidan Wang, Zhijun He, Guanbin Zhang, Mengjie Han, Cong Jin

    Since the UNAIDS introduced HIV self-testing in 2014, its application has been widely adopted globally. Developed in China approximately 2015, HIV self-testing (HIVST), which involves the online purchase of testing kits via e-commerce platforms, has emerged as the most significant distribution method. This approach offers numerous benefits, including user-friendliness, speed, and enhanced privacy protection. To understand the spatiotemporal heterogeneity of online HIVST purchasing behavior and its potential driving factors in China. The online retail sales data of HIVST kits from the two largest e-commerce platforms in China from 2015 to 2020 were collected for this study. The Bayesian spatiotemporal hierarchical model (BSTHM) was used to investigate the spatiotemporal characteristics and identify the rapidly growing high-demand regions of online HIVST kit sales. Furthermore, the BSTHM was used to identify potential driving factors associated with online sales, including college students per 10,000 persons, GDP per capita, net per person, phone per person, population density, road density and HIV screening cases per 10,000 persons. From 2015 to 2020, the sales of online HIVST kits experienced a dramatic surge, increasing from 837,061 kits to reaching 7,827,411 kits annually, with a total of 23,987,155 kits sold, with annual peak sales in December. Four economically superior regions in China, the Pearl River Delta, Yangtze River Delta, Beijing-Tianjin areas, and Shandong Peninsula, presented relatively high spatial preferences for online purchased HIVST kits. Thirty-eight rapidly growing high-demand regions were identified, which were located mainly in northeastern China (28.9%, 11/38), the Pearl River Delta (28.9%, 11/38) and the Beijing-Tianjin areas (15.8%, 6/38). The number of college students per 10,000 persons, GDP per capita, net per person, population density and number of HIV screening cases per 10,000 persons were identified as the driving factors that were positively associated with the online purchase rate of HIVST kits. Our study illuminates the spatiotemporal dynamics and driving factors behind online HIVST kit sales across mainland China, offering pivotal insights for crafting detailed HIVST guidelines. We pinpointed regions with significant sales demand, guiding policymakers in resource reallocation and HIV care continuum optimization, particularly in identified critical ' rapidly growing high-demand’ regions.


  • Open Access

    Platelet CKB as a potential contributor to serum creatine kinase abnormalities and metastasis in cancer patients

    by Lubei Rao, Chao Hu, Yan Yue, Yajun Luo, Bo Ye, Yue Liang, Guanbin Zhang, Dongsheng Wang

    An unusual clinical laboratory phenomenon—serum creatine kinase-MB (CK-MB) activity exceeding total creatine kinase (CK) activity (CK-MB > CK)—is frequently observed in cancer patients, yet its molecular origin and relevance to tumor biology remain unclear. We conducted an integrated analysis combining a large retrospective cancer cohort (n = 1,651), serum CK isoenzyme electrophoresis, and qRT-PCR analysis of paired serum and platelet samples. Public RNA-sequencing datasets, including tumor-educated platelets (TEPs) and single-cell data from lung cancer metastases, were utilized to explore the molecular basis and clinical significance of CK isoenzyme alterations. Colorectal and lung cancers were the most frequently associated malignancies with CK-MB > CK abnormalities, particularly in advanced stages. Electrophoresis and transcript profiling revealed that this paradoxical elevation was driven by aberrant increases in non-cardiac CK isoenzymes, especially brain-type creatine kinase (CK-BB) and mitochondrial CK. A composite index (CK-Sub), integrating CK-BB and mitochondrial CK isoforms, was developed and found to be potentially associated with tumor progression. Notably, CKB mRNA was significantly elevated in platelets from lung cancer patients and exceeded paired serum levels, with a strong positive correlation (R2 = 0.33, p < 0.001), suggesting that platelets may contribute to the circulating isoenzyme pool. This observation was supported by the TEPs RNA-seq data, which confirmed higher CKB expression in lung cancer patients (p = 7.7 × 10⁻11). Single-cell RNA-seq analysis further showed that CKB expression was enriched in metastatic tumor cells but not in primary lesions. Functional gene enrichment analysis revealed associated pathways involved in metabolism, oxidative stress, and intercellular signaling. Our findings suggest that platelet-related CKB may be linked to metastatic potential in lung cancer and represent a previously underrecognized component in cancer-associated biochemical alterations. This study provides novel insights into the non-canonical roles of platelets in cancer biology and highlights CK isoenzyme profiling as a clinically relevant tool for tumor characterization.

  • Open Access

    Longitudinal serum metabolomics predicts therapeutic outcome in acute myeloid leukemia

    by Qing Cai, Wanying Liu, Changjian Yan, Jiazheng Li, Yan Huang, Xiang Li, Qinwen Yang, Xiaoyu Wei, Huilin Yang, Guanbin Zhang, et al.


  • Open Access

    Temporal Trends in Cervical Human Papillomavirus Prevalence Among Females in Xiamen, China (2016-2023): Cross-Sectional Study

    by Zhuju Chen, Erjuan Lin, Mo Chen, Shihan Wang, Qiuyuan Lin, Qingquan Chen, Heng Xue, Guanbin Zhang

    Background: Human papillomavirus (HPV) is a primary causative agent of cervical cancer, accounting for more than 90% of cases worldwide. Epidemiological data on regional HPV prevalence and genotype distribution are critical for tailoring targeted cervical cancer prevention strategies, particularly in regions with limited population-based studies. Objective: This study aimed to investigate temporal trends in the prevalence of overall HPV infection and vaccine-targeted HPV genotypes among females in Xiamen between 2016 and 2023 using annual cross-sectional analyses. Methods: We analyzed retrospective deidentified data from 63,553 females who underwent HPV genotyping of cervical exfoliated cells at Zhongshan Hospital affiliated with Xiamen University from 2016 to 2023. Data on HPV genotyping, age, and detection time were collected from the hospital’s electronic information system. For each year, we conducted a cross-sectional assessment of HPV infection status to calculate annual HPV prevalence. Temporal trends of HPV prevalence were analyzed across 3 pandemic periods (prepandemic: 2016‐2019, pandemic: 2020‐2022, and postpandemic: 2023) and by age groups. Results: The overall HPV prevalence was 25.24% (16,039/63,553), comprising high-risk human papillomavirus (HR-HPV) at 19.26% (12,242/63,553) and low-risk human papillomavirus (LR-HPV) at 10.08% (6409/63,553). Vaccine-targeted HPV prevalence rates were bivalent human papillomavirus at 3.56% (2264/63,553), quadrivalent human papillomavirus at 5.89% (3746/63,553), and nine-valent human papillomavirus at 13.64% (8666/63,553), respectively. Notably, the number of non–vaccine-targeted HPV genotypes accounted for 16.01% (10,177/63,553) of all tested females and 63.45% (10,177/16,039) of HPV-positive cases. The top 5 HR-HPV genotypes were HPV52 (3000/63,553, 4.72%), HPV58 (1895/63,553, 2.98%), HPV53 (1582/63,553, 2.49%), HPV16 (1461/63,553, 2.30%), and HPV39 (1116/63,553, 1.76%), while HPV81 (1407/63,553, 2.21%), HPV61 (1268/63,553, 2%), and HPV6 (1101/63,553, 1.73%) were the most prevalent LR-HPV genotypes. Temporal analysis revealed significant declines in the prevalence of overall HPV, HR-HPV, LR-HPV, bivalent human papillomavirus, quadrivalent human papillomavirus, nine-valent human papillomavirus, and specific genotypes (HPV52, HPV58, HPV16, HPV39, and HPV6) from 2016 to 2019 to 2023 (all P<.001). Conversely, HPV81 prevalence increased significantly in 2023 compared to 2020‐2022 (2.44% vs 1.96%; P<.001). Age-stratified analysis of HPV prevalence showed a significant declining trend with increasing age (P<.001), with peak prevalence observed in the ≤20-year age group. Conclusions: Cervical HPV infection, particularly non–vaccine-targeted genotypes, remains a substantial public health burden in Xiamen, highlighting the urgency to develop broader spectrum vaccines, to enhance cervical cancer screening programs, and to implement age-specific interventions, specifically for females aged ≤20 years. Long-term surveillance of emerging HPV genotypes and vaccination coverage is recommended.


  • Open Access

    Temporal changes in prevalence and geographical distribution of human papillomavirus infection in mainland China: a systematic review and analysis of 1.07 million females from 2010 to 2021

    by Qingquan Chen, Shihan Wang, Qiuyuan Lin, Guanbin Zhang

    Human papillomavirus (HPV) has been identified as a causative agent of cervical cancer. The aim of this study was to investigate temporal changes in prevalence and geographical distribution of human papillomavirus (HPV) infection in mainland China. This study was a systematic review and aggregate data analysis. The literature was searched from multiple databases. The included studies were divided into two groups, the 2010–2016 group and the 2017–2021 group, according to the time period of specimen collection. A total of 17 HPV types were selected. Temporal changes in prevalence and geographical distribution of HPV infection and the effect of the HPV vaccine were analyzed. A total of 1,073,296 females from mainland China were included. The total prevalence of the 17 selected HPV types in 2017–2021 was 26.06% which was significantly higher than the 23.20% in 2010–2016 (P < 0.001). The total prevalence of the 17 selected HPV types significantly increased in 11 regions, among which Jiangxi, Beijing, Chongqing, Inner Mongolia, and Zhejiang increased by more than 1.5 times in 2017–2021 compared to 2010–2016 (P < 0.05). The national prevalence of HPV51, 59, 53, 56, 39, 45, 66, 52, 35, 68 and 58 significantly increased (P < 0.001), while the prevalence of HPV33, 16, 6, and 11 significantly decreased (P < 0.05) in 2017–2021 compared to 2010–2016. The national prevalence of HPV 52, 16, 58, 53, and 51 ranked in the top 5 from 2017-2021. A 10.05% reduction in the national prevalence of 2-HPV type targeted by bivalent vaccine and a 13.09% reduction in that of 4-HPV type targeted by quadrivalent vaccine were found from 2010-2016 through 2017–2021. The prevalence of HPV infection among females remains high and shows a significant increase in the mainland China. The top five most common HPV types in females in 2017–2021 were HPV 52, 16, 58, 53 and 51. Although some effectiveness of HPV vaccination has already been observed, particular attention should be paid to the high prevalence of nonvaccine genotypes including HPV 53 and HPV 51 in mainland China.


  • High-throughput profiling of chemical-induced gene expression across 93,644 perturbations

    by Lei Xiang, Yumei Wang, Wei Shao, Qingzhou Li, Xiankuo Yu, Mingming Wei, Yu Gui, Shengrong Li, Pan Qin, Chao Hu, et al.

    In this Resource, we present an extensive dataset of chemical-induced gene signatures (CIGS), encompassing expression patterns of 3,407 genes regulating key biological processes in 2 human cell lines exposed to 13,221 compounds across 93,664 perturbations. This dataset encompasses 319,045,108 gene expression events, generated through 2 high-throughput technologies: the previously documented high-throughput sequencing-based high-throughput screening (HTS2) and the newly developed highly multiplexed and parallel sequencing (HiMAP-seq). Our results show that HiMAP-seq is comparable to RNA sequencing, but can profile the expression of thousands of genes across thousands of samples in one single test by utilizing a pooled-sample strategy. We further illustrate CIGS’s utility in elucidating the mechanism of action of unannotated small molecules, like ligustroflavone and 2,4-dihydroxybenzaldehyde, and to identify perturbation-induced cell states, such as those resistant to ferroptosis. The full dataset is publicly accessible at https://cigs.iomicscloud.com/.


  • Open Access

    Natural small molecule bergapten ameliorates rheumatoid arthritis by targeting STAT3

    by Jun Xie, Sijuan Sun, Ziyu Zhou, Xiaofang Ma, Qingzhou Li, Shengrong Li, Yan Luo, Guochen Zhang, Yunjie Hu, Guiling Wang, et al.